Advancing the research, education, and treatment of mastocytosis and related mast cell diseases

Saturday, August 22, 2026 | 9:30 AM – 3:15 PM ET

Columbus, OH

Please Register Here!

Announcements

Mast Cell Disease TeleECHO

The Mast Cell Disease Society (TMS) is partnering with Project ECHO to enhance care for our community. Through virtual didactics, case-based discussion, and sharing knowledge, participating physicians will learn from leading experts about evaluating, diagnosing, and treating patients.

Register now at www.tmsforacure.org/echo

Find out more in the AIM Educational Opportunities under the Resources tab.

New Resources Section!

We’re excited to announce our new Educational Opportunities section is now available under the Resources tab. There you’ll find information on webinars, presentations, ISLH Pathology Education, and other learning resources. Visit today to explore all the educational opportunities available to you.

AAAAI/The Mast Cell Disease Society (TMS)

Exciting funding opportunity for researchers! The AAAAI/The Mast Cell Disease Society (TMS) is offering a 2025 Research Award in Mast Cell Disorders, including Mastocytosis and/or Mast Cell Activation Syndrome. This $60,000 one-year award supports innovative research to advance the understanding and treatment of mast cell disorders. Eligible applicants must be independent researchers in the U.S. or Canada with a background in allergy/immunology. Applications are due by October 25, 2024. Learn more about this opportunity and apply here: https://aaaai.execinc.com/edibo/MastCellResearch25

Centers of Excellence

The AIM network includes both Centers of Excellence and Reference Centers. Centers of Excellence include expert clinicians in at least two specialty areas of medicine, although it is recommended to have coverage in the areas of allergy/immunology, hematology, pathology and pediatrics with experience in clinical trials. Reference Centers include expert clinician(s) in at least one specialty area of medicine, and these centers are encouraged to expand their team to include additional specialty areas of medicine and to gain experience in clinical trials. Each Center of Excellence and Reference Center has applied via application and been discussed by the AIM Committee with a vote. Specific individualized feedback is given to each Center. While Centers may ask for a review at any time, they are encouraged to do so every 2 years. Acceptance as a Center indicates permission to be listed on the AIM web site. Please do not hesitate to reach out to the AIM Committee for additional information.

Learn More